Phio Pharmaceuticals (PHIO) Current Assets (2016 - 2021)
Historic Current Assets for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to $27.4 million.
- Phio Pharmaceuticals' Current Assets rose 5578.89% to $27.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $27.4 million, marking a year-over-year increase of 5578.89%. This contributed to the annual value of $15.2 million for FY2020, which is 10772.6% up from last year.
- According to the latest figures from Q3 2021, Phio Pharmaceuticals' Current Assets is $27.4 million, which was up 5578.89% from $31.2 million recorded in Q2 2021.
- Over the past 5 years, Phio Pharmaceuticals' Current Assets peaked at $33.3 million during Q1 2021, and registered a low of $2.9 million during Q1 2018.
- Moreover, its 5-year median value for Current Assets was $11.4 million (2019), whereas its average is $13.4 million.
- As far as peak fluctuations go, Phio Pharmaceuticals' Current Assets tumbled by 7242.77% in 2018, and later surged by 35118.8% in 2019.
- Quarter analysis of 5 years shows Phio Pharmaceuticals' Current Assets stood at $3.8 million in 2017, then soared by 295.35% to $15.2 million in 2018, then plummeted by 51.82% to $7.3 million in 2019, then surged by 107.73% to $15.2 million in 2020, then soared by 81.02% to $27.4 million in 2021.
- Its last three reported values are $27.4 million in Q3 2021, $31.2 million for Q2 2021, and $33.3 million during Q1 2021.